Sounds like you are over your head already, I oppose you taking up the time of the executive.
I want them working on drug development and not bogged down with legal proceedings so you can get 20% of your funds, when you should have considered the risk before investing and not complaining now it is not going to your plan.
I doubt this is the first time a Biotech has underperformed against expectation.
IHL Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held